Stocks and Investing
Stocks and Investing
Thu, February 16, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, February 15, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Dan Leonard Reiterated (ADPT) at Sell and Held Target at $7 on, Feb 15th, 2023
Dan Leonard of Credit Suisse, Reiterated "Adaptive Biotechnologies Corporation" (ADPT) at Sell and Held Target at $7 on, Feb 15th, 2023.
Dan has made no other calls on ADPT in the last 4 months.
There are 3 other peers that have a rating on ADPT. Out of the 3 peers that are also analyzing ADPT, 1 agrees with Dan's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tejas Savant of "Morgan Stanley" Maintained at Hold with Decreased Target to $16 on, Monday, November 7th, 2022
These are the ratings of the 2 analyists that currently disagree with Dan
- Sung Ji Nam of "Scotiabank" Initiated at Buy and Held Target at $15 on, Thursday, January 5th, 2023
- David Westenberg of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $14 on, Wednesday, December 21st, 2022
Contributing Sources